Prefer Dr Reddy's From Pharma Space: Avinnash Gorakssakar

  • 15:24
  • Published On: May 14, 2016
Cinema View
Embed
Market expert Avinnash Gorakssakar says fourth quarter earnings of Dr Reddy's Laboratories were a positive surprise. He is hopeful that outstanding receivables from Venezuela are the last of the write-offs.

Related Videos

Expect Nifty To Hit 10,000 In 3-4 Months: Sumeet Bagadia
May 12, 2017 35:06
Buy Finolex Industries, Tiger Logistics: Avinnash Gorakssakar
April 26, 2017 27:23
D-Mart Qualifies For Premium Rating: Avinnash Gorakssakar
March 22, 2017 36:18
Buy NBCC, Kotak Mahindra Bank, Mahindra Holidays: Avinnash Gorakssakar
March 15, 2017 31:04
Invest In Finolex For Target Of Rs 622: Avinnash Gorakssakar
March 01, 2017 28:08
Buy Finolex Industries, Dewan Housing, NBCC: Avinnash Gorakssakar
February 15, 2017 25:23
Buy RBL Bank, NBCC, HCL Tech: Avinnash Gorakssakar
December 27, 2016 28:12
Hold Bank of Baroda: Avinnash Gorakssakar
September 12, 2016 12:13
NBFCs To Benefit From New Steps To Deepen Bond Market
August 26, 2016 25:00
Like Consumer Durable, Auto Stocks: Prateek Agarwal
July 13, 2016 15:12
Prefer Larsen & Toubro Over BHEL: Avinnash Gorakssakar
July 11, 2016 7:10
Markets Will Settle Down Soon: Avinnash Gorakssakar
June 24, 2016 14:24
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination